Use of oral contraceptives and mortality during 14 years' follow-up of Norwegian women

Abstract

Aims: The aim was to evaluate total and cardiovascular disease (CVD) mortality in relation to use of oral contraceptives (OC) in a cohort of women with a relatively high prevalence of smoking and high serum lipid levels. Methods: In all 29,053 women aged 20—49 years were invited to a health survey in 1985—88. Of the total 82% attended and 20,282 women free of known CVD were included in this analysis. The relative risk (RR) of mortality during 14 years of follow-up was compared between OC users and non-users by means of proportional hazards regression. Results: About 50% of 827 OC users were daily cigarette smokers, and the mean total cholesterol level in the cohort was 5.9 mmol/l. There were 518 deaths, of which 10 occurred among the women taking OC at baseline. Of three deaths from CVD among OC users, two occurred in the first year of follow-up. Among non-smokers using OC three women died during the follow-up; none of the deaths was due to CVD. Women using OC of any type had no different adjusted total mortality (RR 0.87; 95% CI 0.46—1.65) or CVD mortality (RR 1.41; 95% CI 0.44—4.56) compared with non-users. Conclusions: The results were consistent with previous evidence which does not indicate that mortality from all causes or CVD is elevated in women using OC.

Keywords

Cardiovascular disease mortality oral contraceptives

Get full access to this article

View all access options for this article.

References

FR, Van Rosendaal

Hylckama Vlieg A, Tanis BC, Helmerhorst FM. Estrogens, progestogens and thrombosis. J

Thromb Hemost 2003;1:1371—80.

Beral V. , Hermon C. , Kay C. , Hannaford P. , Darby S. , Reeves G. Mortality associated with oral contraceptive use: 25 years follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraceptive study. Br Med J 1999;318:96—100.

Dunn NR , Thorogood M. , Faragher B. , et al. Oral contraceptives and myocardial infarction: Results of the MICA case-control study. Br Med J 1999;318:1579—84.

Tanis BC , van den Bosch Maaj , Kemmeren JM , et al. Oral contraceptives and the risk of myocardial infarction. N Engl J Med 2001;345:1787—93.

Rosenberg L. , Palmer JR , Rao RS , Shapiro SMB Low-dose oral contraceptive use and the risk of myocardial infarction. Arch Intern Med 2001;161:1065—70.

Gillum LA , Mamidipudi SK , Johnston SC Ischemic stroke risk with oral contraceptives: A meta-analysis. JAMA 2000; 284:72—8.

Kumle M. , Alsaker E. , Lund E. Use of oral contraceptives and risk of cancer, a cohort study. Tidsskr Nor Lægeforen 2003;12:1653—6.

World Health Organization. Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. Contraception 1998;57:315—24.

Skegg DCG Oral contraception and health. Long term study of mortality shows no overall effect in a developed country. Br Med J 1999;318:69—70.

10.

Graff-Iversen S. , Tverdal A. , Stensvold I. Cardiovascular risk factors in Norwegian women using oral contraceptives: Result from a cardiovascular health screening 1985—88 . Contraception 1996;53:337—44.

11.

Bjartveit K. , Foss PO , Gjervig T. , Lund-Larsen PG The cardiovascular disease study in Norwegian counties. Background and organization. Acta Med Scand 1985;634 (Suppl):1—70.

12.

Vassenden K. Folke- og boligtellingene 1960, 1970 og 1980. Dokumentasjon av de sammenlignbare filene. Report 87/2. Oslo-Kongsvinger: Statistics Norway; 1986.

13.

Gjertsen F. The Norwegian Causes of Death Register — an important data source for medical research. Tidsskr Nor Lægeforen 2002;122:2551—4.

14.

Håheim LL Validation of cause of death by age. Tidsskr Nor Lægeforen 1999;119:826—30.

15.

Available at http://www.ssb.no/english/subjects/03/01/10/dodsarsak_en/tab-2004-02-27-03-en.html

16.

Graff-Iversen S. 40-years old female sex hormone users: Healthy selections or risk groups? Results from health surveys in 11 Norwegian counties 1997—99. Nor J Epidemiol 2001; 11:73—9.

17.

Royal College of General Practitioners' Oral Contraceptive Study. Further analyses of mortality in oral contraceptive users. Lancet 1981;March 7:541—6.

18.

WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Acute myocardial infarction and combined oral contraceptive: results of an international multicentre case-control study. Lancet 1997;349: 1202—9.

19.

Njolstad I. , Arnesen E. , Lund-Larsen PG Smoking, serum lipids, blood pressure, and sex difference in myocardial infarction. A 12-years follow-up of the Finnmark Study. Circulation 1996;93:450—6.

20.

Foulon T. , Payen N. , Laporte F. , et al. Effects of two low-dose oral contraceptives containing ethinylestradiol and either desogestrel or levonorgestrel on serum lipids and lipoproteins with particular regard to LDL size. Contraception 2001;46:11—16.

21.

Chasan-Taber L. , Willett WC , Manson JE , et al. Prospective study of oral contraceptives and hypertension among women in the United States . Circulation 1996;94: 483—9.